Although we found no evidence that IVM reduced Plasmodium infection rates among surviving mosquitoes , the mosquitocidal effect of AL-IVM1 and AL-IVM2 resulted in 27 % and 35 % reductions , respectively , in estimated malaria transmission potential during the first week after initiation of treatment .